Evidence map›Paper›PMID 40580495›Full record

ArticleThe British journal of dermatology2025

Comprehensive profiling of the mutational landscape of hidradenoma papilliferum validates key role of alterations in the phosphoinositide 3-kinase/AKT pathway.

Saamin Cheema, Louise van der Weyden, Kim Wong, Martin Del Castillo Velasco-Herrera, Jamie Billington, Ian Vermes, Elizabeth Anderson, Laura Allen, Nicolas de Saint Aubain, Michiel P J van der Horst and 9 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The British journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Saamin CheemaWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-5297-2042
Louise van der WeydenWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0002-0645-1879
Kim WongWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Martin Del Castillo Velasco-HerreraWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-5956-0211
Jamie BillingtonWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Ian VermesWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Elizabeth AndersonWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Laura AllenWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Nicolas de Saint Aubain
Michiel P J van der Horst
Ahmed K Alomari
Carolin Mogler
Carlos Monteagudo
Derek Frew
Steven D Billings
Mark J Arends
Ingrid FerreiraWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.
Thomas Brenn
David J AdamsWellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridge, UK.ORCID 0000-0001-9490-0306

Funding

Medical Research Council MR/V000292/1Wellcome TrustWellcome Trust 220540/Z/20/A
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40580495
PMCPMC12532136

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.